Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823972) titled 'Dapagliflozin and Right Heart Recovery After ASD Device Closure' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Assiut University

Condition: ASD2(Secundum Atrial Septal Defect)

Intervention: Device: trans catheter device closure

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2026

Target Sample Size: 70

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07823972

Disclaimer: Curated by ...